Revenue | ₹615.07Cr |
Net Profits | ₹160.69Cr |
Net Profit Margins | 26.13% |
Epigral Ltd’s revenue fell -5.9% since last year same period to ₹615.07Cr in the Q1 2025-2026. On a quarterly growth basis, Epigral Ltd has generated -2.57% fall in its revenue since last 3-months.
Epigral Ltd’s net profit jumped 87.13% since last year same period to ₹160.69Cr in the Q1 2025-2026. On a quarterly growth basis, Epigral Ltd has generated 84.93% jump in its net profits since last 3-months.
Epigral Ltd’s net profit margin jumped 98.85% since last year same period to 26.13% in the Q1 2025-2026. On a quarterly growth basis, Epigral Ltd has generated 89.81% jumped in its net profit margins since last 3-months.
The revenue for Epigral Ltd in the Q1 results 2025 was ₹615.07Cr.
The net profit for Epigral Ltd in the Q1 results 2025 was ₹160.69Cr.
The net profit margin for Epigral Ltd in the Q1 results 2025 was 26.13%.
The revenue for Epigral Ltd in the Q1 results 2024 was ₹653.60Cr.
The net profit for Epigral Ltd in the Q1 results 2024 was ₹85.87Cr.
The net profit margin for Epigral Ltd in the Q1 results 2024 was 13.14%.